Oliver Caplin provides a practitioner’s acute summary and insights on the most recent and precedent setting cases in the areas of Private International Law, IP disputes and their crossover.
Before coming to the Bar, Oliver trained and practised as a medical doctor. As a result of his background, he is developing a predominantly life sciences based commercial and IP practice. He has appeared or advised on cases in both the Patents Court and the IPEC.
In 2017 he was involved in three of the year’s leading pharmaceutical patent disputes concerning where challenges to the validity of a foreign registered patent may be brought: Fujifilm v Abbvie; Chugai v UCB; and Eli Lilly & Co v Genentech Inc.